Secretory Otitis Media
Mostrando 1-10 de 10 artigos, teses e dissertações.
-
1. A case of cavernous hemangioma of the infratemporal fossa causing recurrent secretory otitis media
Brazilian Journal of Otorhinolaryngology. Publicado em: 2022
-
2. Long-term Effects of Unilateral and Bilateral Otitis Media and Myringotomy on Long-Latency Verbal and Non-Verbal Auditory-Evoked Potentials
Abstract Introduction Otitis media (OM) is considered one of the most common reasons patients seek medical care in childhood. The fluctuating nature of hearing loss in cases of OM leads to irregular sound stimulation of the central auditory nervous system. Objectives To analyze the long-latency auditory-evoked potential (LLAEP) by verbal and nonverbal soun
Int. Arch. Otorhinolaryngol.. Publicado em: 2020-12
-
3. (Central) Auditory Processing: the impact of otitis media
OBJECTIVE: To analyze auditory processing test results in children suffering from otitis media in their first five years of age, considering their age. Furthermore, to classify central auditory processing test findings regarding the hearing skills evaluated. METHODS: A total of 109 students between 8 and 12 years old were divided into three groups. The cont
Clinics. Publicado em: 2013-07
-
4. Avaliação do emprego de microeletrocautério na cirurgia da otite média secretora
Este estudo apresenta os resultados de tratamento em 83 pacientes com Idade entre 2–10 anos, que apresentaram otite média secretora com efusão, bilateral ou unilateral, acompanhada ou não de hipertrofia de adenóides e cornetos, no Hospital Universitário São Francisco de Paula da Universidade Católica de Pelotas – UCPel, no período de julho de 199
Publicado em: 2007
-
5. Effect of recolonisation with “interfering” α streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial
BMJ.
-
6. Immunoglobulins of the Middle Ear Fluid in Acute Otitis Media: Relationship to Serum Immunoglobulin Concentrations and Bacterial Cultures
Immunoglobulin concentrations were studied in 255 specimens of middle ear fluid (MEF) from 165 episodes of acute otitis media in children. There were significant amounts of all three major immunoglobulins (Ig) in MEF, the mean concentration of IgA being 39 mg/100 ml, of IgM 63 mg/100 ml, and of IgG 383 mg/100 ml. Secretory component was present in all 10 MEF
-
7. Nasopharyngeal antibodies to pneumococcal pneumolysin in children with acute otitis media.
Pneumolysin, an intracellular protein toxin of all clinically relevant pneumococcal serotypes, is released in vivo during the autolysis of pneumococci and is believed to pave the way for intact pneumococci to invade and cause disease. Therefore, antibodies to pneumolysin should prevent its destructive function. We measured antibodies to pneumococcal pneumoly
-
8. Otitis media in children: local immune response to nontypeable Haemophilus influenzae.
Twenty children experienced 30 episodes of otitis media with effusion due to nontypeable (NT) Haemophilus influenzae in the first 2 years of life. The local and systemic immune responses to homologous strains of NT H. influenzae were determined by an immunodot assay. Strain-specific immunoglobulin G (IgG) antibody predominated in the middle ear fluid (MEF).
-
9. Degradation of human immunoglobulins by proteases from Streptococcus pneumoniae obtained from various human sources.
The ability of Streptococcus pneumoniae to degrade human secretory immunoglobulin A (S-IgA), IgG, and IgM was tested in 102 strains by use of the thin-layer enzyme assay cultivation technique. The strains were isolated from patients with acute phases of otitis media, meningitis, and pneumonia as well as from symptomless carriers. An ability to degrade S-IgA,
-
10. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
Studies in children and adults revealed cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine (CAIV-T) to be well accepted, well tolerated and highly protective against culture-confirmed influenza, and to provide significant health benefits. A 2 year, multicentre, double-blind, placebo-controlled efficacy field trial of CAIV-T in children a